Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 774, Issue , 2015, Pages 25-32

  Russell, Gilandra K ^a   Gupta, Ramesh C ^a   Vadhanam, Manicka V ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

32P postlabeling; Cytochrome P450; Dibenzo a,l pyrene; DNA adducts; Polycyclic aromatic hydrocarbons

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; CUCURBITACIN B; CYANIDIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DELPHINIDIN; DIBENZO[A,L]PYRENE; DIINDOYLMETHANE; ELLAGIC ACID; NUCLEOTIDE; OLTIPRAZ; PLANT MEDICINAL PRODUCT; RESVERATROL; TANSHINONE I; TANSHINONE IIA; UNCLASSIFIED DRUG; WITHAFERIN A; ABIETANE DERIVATIVE; ANTHOCYANIN; BENZO[A]PYRENE DERIVATIVE; CARCINOGEN; CYP1B1 PROTEIN, RAT; DIBENZO(A,L)PYRENE; DIINDOLYLMETHANE; DNA ADDUCT; INDOLE DERIVATIVE; STILBENE DERIVATIVE; TANSHINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DNA ADDUCT; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTHOCYANINS; BENZOPYRENES; CARCINOGENS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP1B1; DITERPENES, ABIETANE; DNA ADDUCTS; INDOLES; MICROSOMES, LIVER; PHYTOCHEMICALS; RATS; STILBENES;

EID: 84925955040     PISSN: 00275107     EISSN: 18792871     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2015.02.003     Document Type: Article

References (29)

1. Cavalieri E.L., Rogan E.G., Higginbotham S., Cremonesi P., Salmasi S. Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene. J. Cancer Res. Clin. Oncol. 1989, 115:67-72.
2. Nesnow S., Ross J.A., Stoner G.D., Mass M.J. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology 1995, 105:403-413.
3. Gescher A.J., Sharma R.A., Steward W.P. Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol. 2001, 2:371-379.
4. Smith W.A., Freeman J.W., Gupta R.C. Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7. Mutat. Res. 2001, 480-481:97-108.
5. Aggarwal B.B., Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005, 4:1201-1215.
6. Park J.Y., Bjeldanes L.F. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat. Chem. Biol. Interact. 1992, 83:235-247.
7. Liu T., Zhang M., Zhang H., Sun C., Yang X., Deng Y., Ji W. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. Eur. J. Pharmacol. 2008, 587:78-84.
8. Kongtun S., Jiratchariyakul W., Kummalue T., Tan-ariya P., Kunnachak S., Frahm A.W. Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina. Planta Med. 2009, 75:839-842.
9. Chun Y.J., Kim M.Y., Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 1999, 262:20-24.
10. Berge G., Ovrebo S., Eilertsen E., Haugen A., Mollerup S. Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br. J. Cancer 2004, 91:1380-1383.
11. Lee C.Y., Sher H.F., Chen H.W., Liu C.C., Chen C.H., Lin C.S., Yang P.C., Tsay H.S., Chen J.J. Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol. Cancer Ther. 2008, 7:3527-3538.
12. Yuan S.L., Wang X.J., Wei Y.Q. Anticancer effect of tanshinone and its mechanisms. Ai Zheng 2003, 22:1363-1366.
13. Zhang Z., Zhang J., Jin L., Song T., Wu G., Gao J. Tanshinone IIA interacts with DNA by minor groove-binding. Biol. Pharm. Bull. 2008, 31:2342-2345.
14. Jayaprakasam B., Zhang Y., Seeram N.P., Nair M.G. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003, 74:125-132.
15. Singletary K.W., Jung K.J., Giusti M. Anthocyanin-rich grape extract blocks breast cell DNA damage. J. Med. Food 2007, 10:244-251.
16. Kausar H., Jeyabalan J., Aqil F., Chabba D., Sidana J., Singh I.P., Gupta R.C. Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Lett. 2012, 325:54-62.
17. Espandiari P., Thomas V.A., Glauert H.P., O'Brien M., Noonan D., Robertson L.W. The herbicide dicamba (2-methoxy-3,6-dichlorobenzoic acid) is a peroxisome proliferator in rats. Fundam. Appl. Toxicol. 1995, 26:85-90.
18. Gupta R.C., Spencer-Beach G. Natural and endogenous DNA adducts as detected by 32P-postlabeling. Regul. Toxicol. Pharmacol. 1996, 23:14-21.
19. Gupta R.C. 32P-postlabelling analysis of bulky aromatic adducts. IARC Sci. Publ. 1993, 11-23.
20. Arif J.M., Gupta R.C. Detection of DNA-reactive metabolites in serum and their tissue distribution in mice exposed to multiple doses of carcinogen mixtures: role in human biomonitoring. Carcinogenesis 1996, 17:2213-2219.
21. Prough R.A., Burke M.D., Mayer R.T. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol. 1978, 52:372-377.
22. Hebbar V., Shen G., Hu R., Kim B.R., Chen C., Korytko P.J., Crowell J.A., Levine B.S., Kong A.N. Toxicogenomics of resveratrol in rat liver. Life Sci. 2005, 76:2299-2314.
23. Teel R.W., Dixit R., Stoner G.D. The effect of ellagic acid on the uptake, persistence, metabolism and DNA-binding of benzo[a]pyrene in cultured explants of strain A/J mouse lung. Carcinogenesis 1985, 6:391-395.
24. Gullett N.P., Ruhul Amin A.R., Bayraktar S., Pezzuto J.M., Shin D.M., Khuri F.R., Aggarwal B.B., Surh Y.J., Kucuk O. Cancer prevention with natural compounds. Semin. Oncol. 2010, 37:258-281.
25. Smith W.A., Gupta R.C. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Carcinogenesis 1996, 17:1285-1290.
26. Neumann H.G. Ultimate electrophilic carcinogens on cellular nucleophilic reactants. A contribution to the discussion on threshold doses of environmental chemicals. Arch. Toxicol. 1974, 32:27-38.
27. Kanakis C.D., Tarantilis P.A., Polissiou M.G., Diamantoglou S., Tajmir-Riahi H.A. An overview of DNA and RNA bindings to antioxidant flavonoids. Cell Biochem. Biophys. 2007, 49:29-36.
28. Potter G.A., Patterson L.H., Wanogho E., Perry P.J., Butler P.C., Ijaz T., Ruparelia K.C., Lamb J.H., Farmer P.B., Stanley L.A., Burke M.D. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 2002, 86:774-778.
29. Piver B., Fer M., Vitrac X., Merillon J.M., Dreano Y., Berthou F., Lucas D. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 2004, 68:773-782.